BRPI0408065A - pó impregnado, processo de fabricação do mesmo e sua utilização - Google Patents

pó impregnado, processo de fabricação do mesmo e sua utilização

Info

Publication number
BRPI0408065A
BRPI0408065A BRPI0408065-3A BRPI0408065A BRPI0408065A BR PI0408065 A BRPI0408065 A BR PI0408065A BR PI0408065 A BRPI0408065 A BR PI0408065A BR PI0408065 A BRPI0408065 A BR PI0408065A
Authority
BR
Brazil
Prior art keywords
manufacturing process
impregnated
phases
powder
hydrophilic
Prior art date
Application number
BRPI0408065-3A
Other languages
English (en)
Inventor
Jerome Besse
Laurence Besse
Myriam Alphonse
Original Assignee
Sarl Galenix Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarl Galenix Innovations filed Critical Sarl Galenix Innovations
Publication of BRPI0408065A publication Critical patent/BRPI0408065A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2995—Silane, siloxane or silicone coating
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2996—Glass particles or spheres
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"Pó IMPREGNADO, PROCESSO DE FABRICAçãO DO MESMO E SUA UTILIZAçãO". A invenção trata de um pó que aumenta a bidisponibilidade e/ou a solubilidade de pelo menos um princípio ativo compreendendo um suporte sólido, inerte, sob forma em partículas impregnado por um meio líquido compreendendo uma fase hidrófoba e uma fase hidrófila, pelo menos um tensoativo e pelo menos um princípio ativo, caracterizado pelo fato de que o(s) princípio(s) ativo(s) é(são) dissolvido(s) em uma das ditas fases hidrófila ou hidrófoba e sob forma de suspensão na outra das ditas fases. Este pó impregnado serve de base para diversas preparações nos domínios farmacêutico, parafarmacêutico, cosmético, de complementos alimentares e agroalimentar.
BRPI0408065-3A 2003-03-06 2004-03-05 pó impregnado, processo de fabricação do mesmo e sua utilização BRPI0408065A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302802A FR2851918B1 (fr) 2003-03-06 2003-03-06 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
PCT/FR2004/000541 WO2004080381A2 (fr) 2003-03-06 2004-03-05 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication

Publications (1)

Publication Number Publication Date
BRPI0408065A true BRPI0408065A (pt) 2006-02-14

Family

ID=32865308

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408065-3A BRPI0408065A (pt) 2003-03-06 2004-03-05 pó impregnado, processo de fabricação do mesmo e sua utilização

Country Status (11)

Country Link
US (1) US7569274B2 (pt)
EP (1) EP1603538A2 (pt)
JP (1) JP4901469B2 (pt)
AU (1) AU2004218859B2 (pt)
BR (1) BRPI0408065A (pt)
CA (1) CA2518200C (pt)
FR (1) FR2851918B1 (pt)
MX (1) MXPA05009440A (pt)
NO (1) NO20054562L (pt)
RU (1) RU2367412C2 (pt)
WO (1) WO2004080381A2 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
KR20070094666A (ko) * 2005-02-25 2007-09-20 에프. 호프만-라 로슈 아게 약제 물질 분산성이 향상된 정제
AU2006249349B2 (en) * 2005-05-26 2012-01-12 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US20080160097A1 (en) * 2006-12-28 2008-07-03 Avon Products, Inc. Method for imparting a cosmetic or therapeutic benefit to a topical surface and process for making
MX2009008935A (es) 2007-02-23 2009-11-02 Gilead Sciences Inc Moduladores de las propiedades farmacocineticas de productos terapeuticos.
US20110097414A1 (en) * 2007-02-26 2011-04-28 Sandal Roshan Lal Pharmaceutical compositions comprising adsorbate of fenofibrate
CN101796120B (zh) * 2007-07-19 2014-11-05 艾梅利斯塔尔克美国股份有限公司 有机硅涂料、制备有机硅涂布制品的方法以及该涂布制品
US10531681B2 (en) 2008-04-25 2020-01-14 Sensient Colors Llc Heat-triggered colorants and methods of making and using the same
MX2010011963A (es) 2008-05-02 2010-12-06 Gilead Sciences Inc Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
US20090298952A1 (en) * 2008-05-07 2009-12-03 Brimmer Karen S Platable soluble dyes
US9113647B2 (en) 2008-08-29 2015-08-25 Sensient Colors Llc Flavored and edible colored waxes and methods for precision deposition on edible substrates
US20100102142A1 (en) * 2008-10-28 2010-04-29 Daria Tagliareni Scent dispenser assembly
RU2448684C2 (ru) * 2009-01-15 2012-04-27 Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН "МНИИЭМ им. Г.Н. Габричевского" Роспотребнадзора) Препарат, содержащий биологически активные действующие вещества
KR100926952B1 (ko) 2009-06-04 2009-11-17 화인케미칼 주식회사 고분자 컴파운드용 오일함유 파우더
US11052029B2 (en) * 2009-06-16 2021-07-06 W. R. Grace & Co.-Conn. Cation compatible metal oxides and oral care compositions containing the metal oxides
BR112012015653B1 (pt) 2009-12-29 2023-09-26 W.R. Grace & Co. -Conn. Composição que compreende um material de sílica particulado poroso e película transparente que compreende a mesma
US10993879B2 (en) 2010-02-08 2021-05-04 Shenzhen Evergreen Therapeutics Co., Ltd. Pulmonary delivery of progestogen
US10987361B2 (en) 2010-02-08 2021-04-27 Shenzhen Evergreen Therapeutics Co., Ltd. Treating auto-immune and auto-inflammatory diseases
ES2773079T3 (es) * 2010-02-08 2020-07-09 Shenzhen Evergreen Therapeutics Co Ltd Métodos para el uso de progestágeno como sensibilizador de glucocorticoides
US10004682B2 (en) 2010-08-24 2018-06-26 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
WO2013037650A1 (fr) * 2011-09-15 2013-03-21 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP2013169146A (ja) * 2012-02-17 2013-09-02 Kabaya Shokuhin Kk 新規清涼菓子およびその製造方法
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
ES2908958T3 (es) * 2013-02-01 2022-05-04 Grace W R & Co Gel de sílice porosa como portador para tecnologías líquidas
WO2014122195A1 (en) 2013-02-06 2014-08-14 Hermes Arzneimittel Gmbh Pharmaceutical compositions incorporating low-dose drugs
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
DK3157506T3 (da) 2014-06-20 2020-11-23 Hermes Arzneimittel Gmbh Smagsmaskeret oral, farmaceutisk sammensætning
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017081725A1 (ja) * 2015-11-09 2017-05-18 花王株式会社 口腔用組成物
CN105456203B (zh) * 2015-12-11 2018-05-15 中国人民解放军63975部队 一种药物-载体模式复合微粉制备方法
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102524880B1 (ko) * 2017-12-21 2023-04-21 한양대학교 산학협력단 하이드로콜로이드 조성물 및 이를 포함하는 바이오 패치
CN109123285A (zh) * 2018-08-27 2019-01-04 上海戚熊实业有限公司 一种太岁浸渍工艺制备的饮用水
JP2023504756A (ja) 2019-12-09 2023-02-06 ニコベンチャーズ トレーディング リミテッド カンナビノイドを含む口腔用製品
EP4076501A4 (en) 2019-12-16 2024-05-08 Rutgers, the State University of New Jersey CONTINUOUS PROCESSES FOR MANUFACTURING IMPREGNATED POROUS SUPPORTS AND FOR MANUFACTURING IMPREGNATED POROUS SUPPORTS CONTAINING PHARMACEUTICAL PRODUCTS
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition
KR102726949B1 (ko) * 2023-12-22 2024-11-06 대가파우더시스템 주식회사 유연성 고체형 지혈제 조성물, 유연성 고체형 지혈제 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468815A (en) * 1973-10-18 1977-03-30 Vymatt Sa Pharmaceutical compositions
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
IT1291362B1 (it) * 1997-05-13 1999-01-07 Vectorpharma Int Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
JP2000026283A (ja) * 1998-07-10 2000-01-25 Nisshin Oil Mills Ltd:The 油性組成物を含有した粉末組成物
DE69942205D1 (de) * 1998-08-13 2010-05-12 Cima Labs Inc Microemulsionen als feste dosisformen zur oralen verabreichung
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
JP5684440B2 (ja) * 2001-02-23 2015-03-11 シーマ・ラブス、インコーポレイテッド 組成物および固形製剤
ITMI20011756A1 (it) * 2001-08-09 2003-02-09 Remedia S R L Composizione farmaceutica comprendente una microemulsione doppia acqua/olio/acqua incorporata in un supporto solido
ITMI20012694A1 (it) * 2001-12-19 2003-06-19 Remedia S R L Composizione farmaceutica comprendente una microemulsione doppia olio/acqua/olio incorporata in un supporto solido

Also Published As

Publication number Publication date
CA2518200C (fr) 2013-04-30
FR2851918B1 (fr) 2006-06-16
US20060182691A1 (en) 2006-08-17
WO2004080381A2 (fr) 2004-09-23
NO20054562L (no) 2005-12-01
MXPA05009440A (es) 2006-04-07
RU2367412C2 (ru) 2009-09-20
CA2518200A1 (fr) 2004-09-23
EP1603538A2 (fr) 2005-12-14
AU2004218859B2 (en) 2009-10-15
NO20054562D0 (no) 2005-10-04
FR2851918A1 (fr) 2004-09-10
JP4901469B2 (ja) 2012-03-21
JP2006519820A (ja) 2006-08-31
WO2004080381A3 (fr) 2005-07-28
US7569274B2 (en) 2009-08-04
RU2005130989A (ru) 2006-08-10
AU2004218859A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
BRPI0408065A (pt) pó impregnado, processo de fabricação do mesmo e sua utilização
FR2811552B1 (fr) Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
CL2004000416A1 (es) Compuestos heterociclicos nitrogenados; composicion farmaceutica; y uso del compuesto para tratar o prevenir una condicion mediada por p38, que consiste en una enfermedad inflamatoria, autoinmune, virosica o neurodegenerativa.
DK1372608T3 (da) Medicinske aerosolformuleringer
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
BR0309093A (pt) Formulação farmacêutica oral sob a forma de suspensão aquosa de microcápsulas permitindo a liberação modificada de amoxicilina
BR0213019B1 (pt) formulaÇço para uso na neutralizaÇço de pelo menos uma substÂncias tàxica.
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
AR027862A1 (es) Separador para suspension liquida
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
DE60121293D1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
FR2857591B1 (fr) Particules comprenant un principe actif sous forme de co-precipite
ES1048828Y (es) Soporte con eje para la bascualcion de la herramienta de cavar.
HN2004000123A (es) Composición agroquimica en suspensión acuosa
ES1049572Y (es) Soporte perfeccionado aplicable para la sustentacion de baldas y similares.
SE0102933D0 (sv) Lipid carrier
ITUD20030196A1 (it) Procedimento per la preparazione di dosaggi farmaceutici contenenti molteplici principi attivi.
ES1048707Y (es) Contenedor modular para la aplicacion de cajones extraibles.
ES1052038Y (es) Soporte para barras, estantes o similares aplicables para la sustentacion de prendas u otros.
ES1053274Y (es) Recipiente isotermico para la elaboracion de bloques de hielo de pequeña dimension.
ES1055503Y (es) Bovedilla para la construccion de forjados o losas de piso, perfeccionada.
BR7903001Y1 (pt) caixa para retenção de gordura, produtos gordurosos e solutos menos densos do que o solvente.
ES1053128Y (es) Envase para liquidos con receptaculo para la incorporacion de elementos auxiliares.
ES1047855Y (es) Soporte perfeccionado, aplicable para la exhibicion de elementos laminares.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/14, 9/20; A61P 15/00

Ipc: A61K 9/14 (2011.01), A61K 9/20 (2011.01), A61P 15/

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.